Otsuka Holdings Co., Ltd. (FRA:OS1)
Germany
· Delayed Price · Currency is EUR 45.40
-1.00 (-2.16%)
At close: Aug 14, 2025, 10:00 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Pharmaceuticals | 1,629.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | 12.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutraceuticals | 557.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutraceuticals Growth | 6.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Products | 33.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Products Growth | -3.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment | 110.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Growth | 2.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other | 91.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -105.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Segment Profit | 285.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Segment Profit Growth | 291.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutraceuticals Segment Profit | 59.78B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutraceuticals Segment Profit Growth | -8.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Products Segment Profit | 23.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Products Segment Profit Growth | 43.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Profit | 7.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Profit Growth | 1737.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Segment Profit | -51.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Segment Profit Growth | 11.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 91.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -105.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 91.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -105.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 699.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 2.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | 1,095.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 16.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 242.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 9.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Others | 292.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Others Growth | 5.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Pharmaceuticals Business Profit | 390.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Business Profit Growth | -9.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutraceuticals Business Profit | 64.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutraceuticals Business Profit Growth | 2.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Products Business Profit | 23.66B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Products Business Profit Growth | 1.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Business Profit | 6.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Business Profit Growth | 18.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Business Profit | -54.91B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Business Profit Growth | -3.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|